{"altmetric_id":4082093,"selected_quotes":["Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial"],"citation":{"altmetric_jid":"ecancerorg","first_seen_on":"2015-06-02T14:27:39+00:00","issns":[],"journal":"ecancer","last_mentioned_on":1433473116,"links":["http:\/\/ecancer.org\/video\/3759\/adjuvant-denosumab-may-preserve-bone-health-in-postmenopausal-breast-cancer-patients--results-of-the-abcsg-18-trial.php"],"title":"Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial. Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial","type":"article","uri":"http:\/\/ecancer.org\/video\/3759\/adjuvant-denosumab-may-preserve-bone-health-in-postmenopausal-breast-cancer-patients--results-of-the-abcsg-18-trial.php"},"altmetric_score":{"score":2.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.1},"context_for_score":{"all":{"total_number_of_other_articles":5190641,"mean":6.1260720832137,"rank":2119490,"this_scored_higher_than_pct":58,"this_scored_higher_than":3044336,"rank_type":"exact","sample_size":5190641,"percentile":58},"similar_age_3m":{"total_number_of_other_articles":175051,"mean":8.8326077577836,"rank":70679,"this_scored_higher_than_pct":58,"this_scored_higher_than":102970,"rank_type":"exact","sample_size":175051,"percentile":58},"this_journal":{"total_number_of_other_articles":8537,"mean":2.973032099344,"rank":2978,"this_scored_higher_than_pct":62,"this_scored_higher_than":5352,"rank_type":"exact","sample_size":8537,"percentile":62},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Science communicators (journalists, bloggers, editors)":1,"Members of the public":2}}},"geo":{"twitter":{"GB":2,"IT":1}}},"counts":{"total":{"posts_count":5},"twitter":{"unique_users_count":4,"unique_users":["ecancer","masbarberi","CCTC_AUCO","anelcabrera"],"posts_count":5}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/ecancer\/status\/605742277093392384","license":"datasift","citation_ids":[4082093],"posted_on":"2015-06-02T14:26:27+00:00","author":{"name":"ecancer","url":"http:\/\/www.ecancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/449503716438056960\/SqsDdkL0_normal.png","description":"ecancer is a not for profit, open access, independent medical education platform, committed to improving cancer communication & education.","id_on_source":"ecancer","tweeter_id":"19975787","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":12889},"tweet_id":"605742277093392384"},{"url":"https:\/\/twitter.com\/ecancer\/status\/606393419062222848","license":"datasift","citation_ids":[4082093],"posted_on":"2015-06-04T09:33:52+00:00","author":{"name":"ecancer","url":"http:\/\/www.ecancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/449503716438056960\/SqsDdkL0_normal.png","description":"ecancer is a not for profit, open access, independent medical education platform, committed to improving cancer communication & education.","id_on_source":"ecancer","tweeter_id":"19975787","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":12889},"tweet_id":"606393419062222848"},{"url":"https:\/\/twitter.com\/masbarberi\/status\/606395321971843072","license":"datasift","rt":["ecancer"],"citation_ids":[4082093],"posted_on":"2015-06-04T09:41:25+00:00","author":{"name":"Massimo Barberi","url":"http:\/\/www.clorofillaweb.it","image":"https:\/\/pbs.twimg.com\/profile_images\/425013746998996993\/wGqjY4zB_normal.jpeg","description":"Journalist, pharmacologist and dad. Publishing director at Clorofilla. Editor in chief at Notiziemediche.it and Microbioma.it","id_on_source":"masbarberi","tweeter_id":"94046934","geo":{"lt":45.46427,"ln":9.18951,"country":"IT"},"followers":2619},"tweet_id":"606395321971843072"},{"url":"https:\/\/twitter.com\/CCTC_AUCO\/status\/606395779058507776","license":"datasift","rt":["ecancer"],"citation_ids":[4082093],"posted_on":"2015-06-04T09:43:14+00:00","author":{"name":"SheffCancerResearch","url":"http:\/\/www.sheffield.ac.uk\/oncology-metabolism\/research\/clinical-oncology\/index","image":"https:\/\/pbs.twimg.com\/profile_images\/875683918174973953\/M_R0VXu-_normal.jpg","description":"Sheffield Cancer Clinical Trials Centre at @sheffielduni & @sheffieldhosp - delivering cancer research to local patients","id_on_source":"CCTC_AUCO","tweeter_id":"3291286726","geo":{"lt":53.38297,"ln":-1.4659,"country":"GB"},"followers":525},"tweet_id":"606395779058507776"},{"url":"https:\/\/twitter.com\/anelcabrera\/status\/606656338656006145","license":"datasift","rt":["ecancer"],"citation_ids":[4082093],"posted_on":"2015-06-05T02:58:36+00:00","author":{"name":"Paula Cabrera","image":"https:\/\/pbs.twimg.com\/profile_images\/652861142881046528\/5Bmn7Qk-_normal.jpg","description":"Onc\u00f3loga M\u00e9dica. Apasionada de su trabajo, luchando por una oncolog\u00eda de calidad. INCAN Breast Unit Mexico","id_on_source":"anelcabrera","tweeter_id":"222640718","geo":{"lt":null,"ln":null},"followers":324},"tweet_id":"606656338656006145"}]}}